Time trends in the risk of delayed cerebral ischemia after subarachnoid hemorrhage

Autor: Luigi Rigante, Jasper Hans van Lieshout, Mervyn D. I. Vergouwen, Carlijn H. S. van Griensven, Priya Vart, Lars van der Loo, Joost de Vries, Ruben Saman Vinke, Nima Etminan, Rene Aquarius, Andreas Gruber, J Mocco, Babu G. Welch, Tomas Menovsky, Catharina J. M. Klijn, Ronald H. M. A. Bartels, Menno R. Germans, Daniel Hänggi, Hieronymus D. Boogaarts
Přispěvatelé: MUMC+: MA AIOS Neurologie (9), MUMC+: MA AIOS Neurochirurgie (9), RS: FHML non-thematic output, University of Zurich, Rigante, Luigi
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Time Factors
Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]
VASOSPASM
610 Medicine & health
CASE-FATALITY
Brain Ischemia
10180 Clinic for Neurosurgery
All institutes and research themes of the Radboud University Medical Center
Humans
Vasospasm
Intracranial

Randomized Controlled Trials as Topic
Other Research Radboud Institute for Health Sciences [Radboudumc 0]
General Medicine
Subarachnoid Hemorrhage
Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3]
2746 Surgery
Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]
meta-analysis
2728 Neurology (clinical)
delayed ischemic neurologic deficit
cerebral vasospasm
delayed cerebral ischemia
Surgery
Neurology (clinical)
Human medicine
aneurysmal subarachnoid hemorrhage
Renal disorders Radboud Institute for Health Sciences [Radboudumc 11]
CLINICAL-TRIALS
Zdroj: Neurosurgical Focus, 52(3):2. American Association of Neurological Surgeons
Neurosurgical Focus, 52
Neurosurgical Focus, 52, 3
Neurosurgical Focus
ISSN: 1092-0684
Popis: OBJECTIVE Delayed cerebral ischemia (DCI) contributes to morbidity and mortality after aneurysmal subarachnoid hemorrhage (aSAH). Continuous improvement in the management of these patients, such as neurocritical care and aneurysm repair, may decrease the prevalence of DCI. In this study, the authors aimed to investigate potential time trends in the prevalence of DCI in clinical studies of DCI within the last 20 years. METHODS PubMed, Embase, and the Cochrane library were searched from 2000 to 2020. Randomized controlled trials that reported clinical (and radiological) DCI in patients with aSAH who were randomized to a control group receiving standard care were included. DCI prevalence was estimated by means of random-effects meta-analysis, and subgroup analyses were performed for the DCI sum score, Fisher grade, clinical grade on admission, and aneurysm treatment method. Time trends were evaluated by meta-regression. RESULTS The search strategy yielded 5931 records, of which 58 randomized controlled trials were included. A total of 4424 patients in the control arm were included. The overall prevalence of DCI was 0.29 (95% CI 0.26–0.32). The event rate for prevalence of DCI among the high-quality studies was 0.30 (95% CI 0.25–0.34) and did not decrease over time (0.25% decline per year; 95% CI −2.49% to 1.99%, p = 0.819). DCI prevalence was higher in studies that included only higher clinical or Fisher grades, and in studies that included only clipping as the treatment modality. CONCLUSIONS Overall DCI prevalence in patients with aSAH was 0.29 (95% CI 0.26–0.32) and did not decrease over time in the control groups of the included randomized controlled trials.
Databáze: OpenAIRE